查詢結果分析
相關文獻
頁籤選單縮合
題 名 | The Interactions Between GPR30 and the Major Biomarkers in Infiltrating Ductal Carcinoma of the Breast in an Asian Population |
---|---|
作 者 | Kuo, Wen-hung; Chang, Li-yun; Liu, Daisy Li-yu; Hwa, Hsiao-lin; Lin, Jen-jen; Lee, Po-huang; Chen, Chiung-nien; Lien, Huang-chun; Yuan, Ray-hwang; Shun, Chia-tung; Chang, King-jen; Hsieh, Fon-jou; | 書刊名 | Taiwanese Journal of Obstetrics & Gynecology |
卷 期 | 46:2 2007.06[民96.06] |
頁 次 | 頁135-145 |
分類號 | 416.226 |
關鍵詞 | Estrogen receptor α; G-protein-coupled receptor 30; Human epidermal growth factor receptor-2; mRNA; Progesterone receptor; |
語 文 | 英文(English) |
英文摘要 | Objective: G-protein-coupled receptor 30 (GPR30) has been reported to be a novel estrogen receptor α (ERα) in vitro. Therefore, the interactions among GPR30, ERα, progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2/neu), and their prognostic utilities in the infiltrating ductal carcinoma (IDC) of the breast were evaluated. Materials and Methods: Messenger RNA (mRNA) levels of GPR30, ERα, PR and HER-2/neu in the tumor samples of 118 Taiwanese IDC patients and 27 non-tumor mammary tissues were measured via quantitative polymerase chain reaction analyses. The correlations of GPR30 mRNA levels with clinical parameters, i.e. tumor/non-tumor, ERα, PR, HER-2/neu, age, lymph node metastasis, lymph–vascular invasion, grade, stage and patient survival, were assessed by using appropriate statistical analyses. Results: GPR30 expression was observed to be lower in IDC (p<0.001) than in non-tumor mammary tissues. Importantly, GPR30 mRNA level was positively correlated with that of ERα (p=0.001) and PR (p=0.001) but not correlated with that of HER-2/neu when they were analyzed as continuous variables. However, lower GPR30 was noticed in tumors with HER-2/neu protein overexpression. GPR30 expression was not correlated with age, lymph node metastasis, lymph-vascular invasion, grade and stage in IDC. GPR30 expression was not an independent prognostic factor for patient survival. Conclusion: GPR30 expression is downregulated in IDC. GPR30 is preferentially co-expressed with ER and/or PR but is lowly expressed in HER-2/neu(+) tumors. The correlation of GPR30 expression with clinical parameters, including patient survival, was not evident in this cohort. |
本系統中英文摘要資訊取自各篇刊載內容。